CITIGROUP INC

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 831001 NEW YORK, NY

Position in OBIO

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$108,498

+$27,748 QoQ

Shares Held

25,529

+31.2% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. OBIO ranks #202 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$108,498	25,529	+31.2%	Shares	Defined	2026-05-11
2025-12-31	$80,750	19,458	+47358.5%	Shares	Defined	2026-02-13
2025-09-30	$101	41	-99.5%	Shares	Defined	2025-11-10
2025-06-30	$20,530	7,661	-55.5%	Shares	Defined	2025-08-11
2025-03-31	$73,691	17,218	-10.5%	Shares	Defined	2025-05-12
2024-12-31	$76,988	19,247	+14.2%	Shares	Defined	2025-02-12
2024-09-30	$86,609	16,850	+227.1%	Shares	Defined	2024-11-12
2024-06-30	$41,988	5,152	+114.4%	Shares	Defined	2024-08-12
2024-03-31	$12,663	2,403	+16.0%	Shares	Defined	2024-05-10
2023-12-31	$18,908	2,071	+103450.0%	Shares	Defined	2024-02-09
2023-09-30	$17	2	-99.9%	Shares	Defined	2023-12-06
2023-06-30	$10,948	1,564	—	Shares	Defined	2023-08-10
No filing history on record for this holder in this stock.